G
688046
vs
S
Shanghai Composite
Over the past 12 months, GemPharmatech Co Ltd has significantly outperformed Shanghai Composite, delivering a return of +47% compared to the Shanghai Composite's +27% growth.
Stocks Performance
688046 vs Shanghai Composite
Performance Gap
688046 vs Shanghai Composite
Performance By Year
688046 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
GemPharmatech Co Ltd
Glance View
GemPharmatech Co., Ltd. engages in research and development, manufacture, and sale of experimental mouse models. The company is headquartered in Nanjing, Jiangsu and currently employs 1,342 full-time employees. The company went IPO on 2022-04-25. The firm uses gene-editing and other technologies to produce mouse models. The firm also involves in the business of customized model breeding, drug efficacy analysis, and model customization. The Company’s products are mainly used to satisfy the experimental demands in the fields of gene function cognition, disease mechanisms analysis, drug target discovery, and other fundamental researches.
